Literature DB >> 21453199

Ethical issues regarding the donation and source of cells for tissue engineering: a European focus group study.

Anke J M Oerlemans1, Paul P van den Berg, Evert van Leeuwen, Wim J M Dekkers.   

Abstract

This article is part of the EuroSTEC project, which aims at developing tissue engineering-based treatments for structural disorders present at birth. EuroSTEC is positioned at the intersection of three areas with their own ethical issues: (1) regenerative medicine, (2) research with pregnant women and fetuses, and (3) research with neonates. Because of the link between these three areas in this project, one can expect to be confronted with new ethical challenges. To be able to respond adequately and timely to current and possible future ethical issues, a prospective and anticipatory ethical analysis is essential. To obtain a first impression of the ethical issues that might arise during the different phases of the project, a Delphi method was used. On the basis of the results of two previous rounds of questionnaires, two topics were selected for discussion in focus groups: ethical issues associated with (1) source of cells and (2) donation. The results could be divided into three clusters: Tissue, Donor, and Scientist. Where the former two clusters roughly coincide with the results of the previous rounds, the third subject was entirely new but discussed by both groups: the role of the scientist in the tissue engineering process.

Entities:  

Mesh:

Year:  2011        PMID: 21453199     DOI: 10.1089/ten.TEB.2010.0683

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  2 in total

1.  Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.

Authors:  A J M Oerlemans; M E C van Hoek; E van Leeuwen; S van der Burg; W J M Dekkers
Journal:  Sci Eng Ethics       Date:  2012-11-15       Impact factor: 3.525

Review 2.  Tissue engineered constructs: perspectives on clinical translation.

Authors:  Lichun Lu; Harvey M Arbit; James L Herrick; Suzanne Glass Segovis; Avudaiappan Maran; Michael J Yaszemski
Journal:  Ann Biomed Eng       Date:  2015-02-25       Impact factor: 3.934

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.